Akers Biosciences, Inc. (NASDAQ: AKER) today announces the pricing of an underwritten public offering with expected total gross proceeds of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE